From first to the second European Stroke Prevention Study

A number of recent publications have shown that secondary prevention of cerebrovascular ischemic brain events is possible with anti-aggregating drugs. Comparison between the different studies is difficult, but the results obtained with using a combination therapy with aspirin (ASA) and dipyridamole (DP) seem to be superior to the results obtained with ASA alone. The first European Stroke Prevention Study (ESPS 1), that used 990 mg ASA and 225 mg DP a day, showed this clearly. In an attempt to minimize the side effects of a large dose ASA and possibly even to improve the efficacy, ESPS 2 was established. ESPS 2 will compare 50 mg ASA, 400 mg DP, the combination of both, and placebo.Biomedical Reviews 1993; 2: 31-35

Correspondence: From Joseph J. Lowenthal to Lynwood Roberts, 1972-02-09

Joseph Lowenthal discusses the problems with the Duval Medical Center, it\u27s history, and it\u27s future going forwar

Report: Report on Joseph J. Lowenthal Letterhead , 1969-09-08

A report on the state of the Duval Medical Center. Included are handwritten notes

Luminosities of H alpha emitting regions in a pair of interacting galaxies in the Bootes void

Luminosities of H alpha emission from a pair of interacting galaxies in the low density environment of the Bootes void are presented. CG 692 (IRAS 1519+5050) has an H alpha luminosity of 2 x 10(exp 42) ergs s(exp -1), indicating a star formation rate of 18.4 solar mass yr(exp -1). Individual extranuclear H alpha regions have luminosities of approximately 10(exp 40) ergs s(exp -1). These luminosities are similar to those found for H II regions in bright, late-type galaxies in more densely populated parts of the Universe

Total Molecular Gas Masses of Planck - Herschel Selected Strongly Lensed Hyper Luminous Infrared Galaxies

We report the detection of CO(1 - 0) line emission from seven Planck and Herschel selected hyper luminous (LIR(8-1000um) > 10^13Lsun) infrared galaxies with the Green Bank Telescope (GBT). CO(1 - 0) measurements are a vital tool to trace the bulk molecular gas mass across all redshifts. Our results place tight constraints on the total gas content of these most apparently luminous high-z star-forming galaxies (apparent IR luminosities of LIR > 10^(13-14) Lsun), while we confirm their predetermined redshifts measured using the Large Millimeter Telescope, LMT (zCO = 1.33 - 3.26). The CO(1 - 0) lines show similar profiles as compared to Jup = 2 -4 transitions previously observed with the LMT. We report enhanced infrared to CO line luminosity ratios of = 110 (pm 22) Lsun(K km s^-1 pc^-2)^-1 compared to normal star-forming galaxies, yet similar to those of well-studied IR-luminous galaxies at high-z. We find average brightness temperature ratios of = 0.93 (2 sources), = 0.34 (5 sources), and = 0.18 (1 source). The r31 and r41 values are roughly half the average values for SMGs. We estimate the total gas mass content as uMH2 = (0.9 - 27.2) x 10^11(alphaCO/0.8)Msun, where u is the magnification factor and alphaCO is the CO line luminosity to molecular hydrogen gas mass conversion factor. The rapid gas depletion times are, on average, tau = 80 Myr, which reveal vigorous starburst activity, and contrast the Gyr depletion timescales observed in local, normal star-forming galaxies.Comment: published in MNRAS, 9pages, 5fig

Absolute activity measurements of molybdenum 99 and 4π-γ ion chamber measurements of technetium 99m and of molybdenum 99 with ingrown technetium 99m.

The activity of molybdenum 99 freshly separated from technetium is absolutely measured to ± 1.8 per cent, by 4πв-γ coincidence counting. Internal conversion effects are allowed for and the completeness of the separation is checked from the growth rate of technetium 99m activity as measured in a 4П gamma ionisation chamber. The chamber has been calibrated for molybdenum 99 with ingrown technetium 99m and for pure technetium 99m and serves for routine activity measurements of solutions of these nuclides to an accuracy of ± 3 per cent